Home Cart Sign in  
Chemical Structure| 496775-62-3 Chemical Structure| 496775-62-3

Structure of Eltrombopag Olamine
CAS No.: 496775-62-3

Chemical Structure| 496775-62-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Eltrombopag olamine is an orally active thrombopoietin-receptor (c-mpl) agonist that stimulates thrombopoiesis.

Synonyms: Eltrombopag diethanolamine salt; SB-497115GR; SB497115,SB-497115-GR

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Eltrombopag Olamine

CAS No. :496775-62-3
Formula : C29H36N6O6
M.W : 564.63
SMILES Code : O=C(C1=CC(C2=CC=CC(N/N=C3C(C)=NN(C4=CC=C(C)C(C)=C4)C/3=O)=C2O)=CC=C1)O.NCCO.NCCO
Synonyms :
Eltrombopag diethanolamine salt; SB-497115GR; SB497115,SB-497115-GR
MDL No. :MFCD22380664
InChI Key :DJMJHIKGMVJYCW-UHFFFAOYSA-N
Pubchem ID :135449331

Safety of Eltrombopag Olamine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H319-H412
Precautionary Statements:P273-P305+P351+P338

Isoform Comparison

Biological Activity

Description
Eltrombopag Olamine (Eltrombopag diethanolamine salt) is an orally active thrombopoietin receptor nonpeptide agonist. Eltrombopag owns thrombopoietic activity, and has been used to research low blood platelet counts with chronic immune thrombocytopenia and the research of cardiovascular[1].[2].[3].[4].[5].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01830660 Healthy Phase 1 Completed - China, Sichuan ... More >> West China Hospital, Sichuan University Chengdu, Sichuan, China Less <<
NCT02158936 Thrombocytopaenia Phase 3 Terminated - -
NCT01957176 Thrombocytopaenia Phase 4 Active, not recruiting January 1, 2024 Argentina ... More >> Novartis Investigative Site La Plata, Buenos Aires, Argentina, B1900AXI Belgium Novartis Investigative Site Leuven, Belgium, 3000 China Novartis Investigative Site Shanghai, China, 200025 France Novartis Investigative Site Paris Cedex 12, France, 75571 Greece Novartis Investigative Site Athens, Greece, 11527 Novartis Investigative Site Heraklion, Crete, Greece, 71201 Hong Kong Novartis Investigative Site Shatin, Hong Kong Hungary Novartis Investigative Site Debrecen, Hungary, 4012 Ireland Novartis Investigative Site Tullamore, Ireland Israel Novartis Investigative Site Tel Aviv, Israel, 64239 Korea, Republic of Novartis Investigative Site Seoul, Korea, Republic of, 136-705 Netherlands Novartis Investigative Site Amsterdam, Netherlands, 1081 HV Peru Novartis Investigative Site San Isidro, Lima, Peru, Lima 27 Poland Novartis Investigative Site Chorzow, Poland, 41-500 Romania Novartis Investigative Site Bucharest, Romania, 022328 Tunisia Novartis Investigative Site Montfleury, Tunisia, 1008 Novartis Investigative Site Sousse, Tunisia, 4000 Less <<
NCT02158936 - Terminated - -
NCT00903422 Myelodysplastic Syndrome Phase 1 Completed - -
NCT00370331 Purpura, Thrombocytopaenic, Id... More >>iopathic Less << Phase 3 Completed - -
NCT02201290 Purpura, Thrombocytopenic, Idi... More >>opathic Less << Phase 3 Completed - Russian Federation ... More >> Novartis Investigative Site Krasnodar, Russian Federation, 350007 Novartis Investigative Site Moscow, Russian Federation, 117997 Novartis Investigative Site Saint Petersburg, Russian Federation, 198205 Less <<
NCT00424177 - Completed - -
NCT00643929 - Completed - -
NCT00424177 Purpura, Thrombocytopaenic, Id... More >>iopathic Less << Phase 2 Completed - Germany ... More >> GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Berlin, Germany, 13353 Russian Federation GSK Investigational Site Moscow, Russian Federation, 125167 Less <<
NCT01147809 - Completed - -
NCT00370331 - Completed - -
NCT00351468 - Completed - -
NCT01147809 Thrombocytopaenia Phase 2 Completed - -
NCT01098487 Purpura, Thrombocytopaenic, Id... More >>iopathic Less << Phase 4 Completed - -
NCT01610180 Purpura, Thrombocytopenic, Idi... More >>opathic|Autoimmune Thrombocytopenic Purpura|Autoimmune Thrombocytopenia|Chronic Lymphocytic Leukemia|Non Hodgkin's Lymphoma Less << PHASE2 COMPLETED 2018-06-30 Department of Hematology, Ospe... More >>dale San Bortolo, Vicenza, 36100, Italy Less <<
NCT00351468 Purpura, Thrombocytopaenic, Id... More >>iopathic Less << Phase 3 Completed - -
NCT01927731 Bone Marrow Transplantation Re... More >>cipient Cord Blood Transplant Recipient Hematopoietic Cell Transplantation Recipient Less << Phase 2 Active, not recruiting October 31, 2019 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01098487 - Completed - -
NCT02071901 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Less << Phase 2 Active, not recruiting December 2018 United States, Ohio ... More >> Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT01550185 Adult Acute Basophilic Leukemi... More >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << Phase 1 Terminated(Sponsor wanted stud... More >>y rewritten) Less << - United States, Georgia ... More >> Emory University, Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT01772420 Adult Myelodysplastic Syndrome... More >> Anemia Chronic Myelomonocytic Leukemia Less << Phase 2 Unknown - United States, Kansas ... More >> University of Kansas Cancer Center Recruiting Kansas City, Kansas, United States, 66160 Contact: Suman Kambhampati    913-588-6029    skambhampati@kumc.edu    Principal Investigator: Suman Kambhampati          United States, New York Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Amit K. Verma    718-430-8761    amit.verma@einstein.yu.edu    Principal Investigator: Amit K. Verma Less <<
NCT01428635 Accelerated Phase Chronic Myel... More >>ogenous Leukemia, BCR-ABL1 Positive|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Primary Myelofibrosis|Thrombocytopenia Less << PHASE2|PHASE3 COMPLETED 2022-01-03 M D Anderson Cancer Center, Ho... More >>uston, Texas, 77030, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.77mL

0.35mL

0.18mL

8.86mL

1.77mL

0.89mL

17.71mL

3.54mL

1.77mL

References

 

Historical Records

Categories